.Background: The appropriate approach to women with mild dyskaryotic changes on Papanicolaou smear is subject to controversy. Our aim was to assess the usefulness of cervicography as a diagnostic test in detecting cervical cancer or its precursors.
ter application of acetic acid. The resulting cervigram is then examined by an expert who looks for evidence of pathologic changes consistent with a dysplastic process. If the changes are found, the patient is referred for colposcopy and directed biopsies. 3 ,4 When compared with colposcopy, the advantages of cervicography are that it is simple to perform, less expensive, and noninvasive.
Development of a new diagnostic test has particular relevance for detection of cervical cancer and its precursors. Recently the debate has intensified over the appropriate management for women with atypical or low-grade cytologic abnormalities. Management can range from immediate colposcopy to watchful waiting with repeat Papanicolaou smears. 5 -7 A new diagnostic test such as cervicography can have an impact on both of these strategies.
Before adoption and diffusion of cervicography become widespread, it is important to review the existing evidence on the performance characteristics of this test. Our study reviewed the published research on cervicography and addressed the following question: Is cervicography useful as a pri- Each eligible report was reviewed using a quality assessment instrument. The quality assessment criteria, adapted from previous works on assessment of diagnostic test research, are listed in ' Table 2 .')-11 Two of the authors (fN,]M) independently reviewed each article for quality assessment criteria. Disagreements were discussed, and the final scoring wa~ assigned by consensus.
For each eligible report the percentage of unsatisfactory or technically defective cervi grams and the results of colposcopy (normal, any dysplasia, low-grade dysplasia, high-grade dysplasia, and cancer) were extracted. Sensitivity, specificity, positive predictive value, negative predictive value, disease prevalence, and likelihood ratios for a positive test result (true-positive ratelfalse-positive rate) and for a negative result (false-negative rate/true-negative rate) were calculated. Truepo~itive cervigrarns were defined as those that had histologic findings on colposcopy of either any 392 JABFP Nov.-Dec. 1997 VoL 10 No.6 dysplasia or of only high-grade dysplasia. The test calculations included and then excluded unsatist"<lctory or technically defective cervigrams in all den()JJlina tors.
Results

Baseline Data
]wenty-three reports on cervicography were retrieved using the search strategy described above. I ,12-H After eliminating those studies in which the reference standard (colposcopy) was not performed on all participants, scven studies remained. Baseline data and methodologies are summarized in ]llble 1 y-n The studies, published from 1 <)87 to 1 <)<) 3, had a variety of study populations, and the entry criteria for the study varied widely. In three of the studies eligible women had atypical Papanicolaou smear findings 2 >l,lO,I\ in two, the women were those who were scheduled to be seen in a referral colposcopy clinic. n , 32 The study by Cecchini et al27 included patients seen in a referral colposcopy clinic for abnormal Papanicolaou smear findings (including atypia and dysplasia) and self-referred patients with normal Papanicolaou smear findings. No information is provided on the breakdown of cytologic findings that precipitated colposcopy in the study by Soutter et alY In the study by Kesic et al,2') eligible participants were from a "screening population," most of whom had never had a previous Papanicolaou smear. In a study by Schauberger et al,31 those who had all active condyloma, a history of condyloma, or a partner with condyloma were eligible. The wide differences in entry criteria and study I->,lrticipant~ lllade mctaanalytic techniques inappropriatc. II Cervigrams described as unsatisfactory or technically defective ranged from 2.0 to 15.5 percent (median = '7.7 percent) among the eligible studies.
Quality Assessment
Results of the quality assessment scoring are presented in Elble 2. No study received a score of greater than 3 (with a maximum possible score (0).
Test Parameters
The results of the scnsitivity, specificity, positive predictive values, ncgative predictivc values, disease prevalence and likelihood ratios are presented in 'Elble 3. The values incorporate technically defective or unsatisfactory cervigrallls ill all denominators. There was no substantive difference in the analysis by inclusion or exclusion of these cervi grams.
There is a considerable difference in positive predictive value within each of the studies when comparing the detection of any dysplasia with high-grade dysplasia. The positive predictive values for detection of any dysplasia (median 41.1 percent, range 21.9 to 45.5 percent) were greater than the positive predictive values for detection of high-grade dysplasia (median 10.9 percent, range 5.4 to 31.5 percent).
The difference between the positive predictive value (ie, the posttest likelihood of disease if the test results are positive) and disease prevalence (ie, the pretest likelihood of disease) was small for high-grade lesions. The false-positive rate was generally high. It ranged from 8.2 to 61.0 percent (median 42.1 percent) for the histologic finding of any dysplasia and 9.8 to 63.4 percent (median 50.6 percent) for high-grade lesions. Likelihood ratios for a positive result ranged from 1.0 to 2.3 for six of the seven studies. The study by Kesic et aF9 represents an outlier, as it had relatively higher values for most of the test parameters evaluated. This study was the only one using cervicography as a primary screening test. The negative predictive values for most of the studies were high, particularly for high-grade dysplasias (range 88.8 to 100 percent). The calculated likelihood ratios for a negative test result ranged from 0.12 to 0.97 for any dysplasia and from 0.02 to 1.0 for high-grade dysplasias. In four of the six studies reporting both any dysplasia and high-grade dysplasia,27,28,31,H the likelihood ratio for a negative result was substantially lower for high-grade lesions (0.02 to 0.24) than for any lesion (0.18 to 0.44).
Only one study examined interobserver variability of cervi grams. Cecchini et aJ27 found good interobserver agreement beyond chance using two independent reviewers of cervi grams (kappa = 0.(2).
Discussion
Quality of Research on Cervicography
The quality of research on cervicography is generally poor. Sixteen of the 23 retrieved reports did not apply the reference standard of colposcopy to all test participants. The most common methodologic error was to perform colposcopy only on those participants with positive findings on either Papanicolaou smear or cervi gram. It has been well-documented that the properties of a diagnostic test will be distorted if its results influence whether patients undergo confirmation by a reference standard. 34 This problem has been described as ascertainment, verification, or workup bias. This bias will falsely increase the sensitivity of the test being evaluated, because the number of false-negative results is unknown if patients with a negative test result do not receive the reference standard test. 34 The findings also indicate that the seven eligible studies did not adequately address nine accepted methodologic standards for the evaluation of diagnostic tests. Inadequate appraisal of diagnostic tests in the medical literature has been previously reportedY
Cervicography Test Characteristics
Cervicography has a high false-positive rate. Our analysis documents a false-positive rate that ranged from 8.2 to 61.0 percent (median 42.1 percent) for any dysplasia and 9.8 to 63.4 percent (median 50.6 percent) for high-grade lesions. Similar ranges of false-positive rates are reported in the studies excluded from the overview. This problem is not surprising and not without precedent. During colposcopic examination of the cervix, many different processes in the transformation zone can mask the underlying blood vessels by focally increasing the cell density. Overlap between the acetowhite changes occurs not only as a result of dysplasia but also as a result of inflammation and squamous metaplasia and condyloma without dysplasia. It is predictable that differentiation on cervicography of low-grade dysplasias from these other processes is not reli-able. 3s The relatively high frequency of l1oJ1diag-nostic histologic findings after colposcopy, ie, 29.0 to 45.4 percent of colposcopy-directed biopsies, is also consistent with this range of false-positive findings. , r.-3H When cervicography is llsed as an adjunct to a Papanicolaou smear, the impact of a high falsepositive rate would be a high-recall rate for repeat examinations or excessive referrals for colposcopic examination. Although only women with precancerous changes or cancer of the cervix are at risk for a false-negative test result, all women without disease who are screened are at risk for a false-positive result. H Cervicography has a high sensitivity (low falsenegative rate) for high-grade dysplasia. In six of the seven studies cervicography had a high sensitivity (89.5 to 100 percent) for high-grade dysplasia. In three of these studies, the sensitivity was 100 percent. The likelihood ratio for a negative test result ranged from 0.02 to 0.24 for highgrade dysplasia in six of the seven eligible studies.
The percentage of defective or unsatisfactory cervigrams poses a problem for general applicability of cervicography. There was a wide range in defective or unsatisfactory cervi grams; from 2.0 to 15.5 percent. A defective cervigram results from either improper technique or the inability to visualize the transformation zone adequately, a common problem in postmenopausal women. The study by Spitzer et a133 was the only one to address the issue of cervicography in this group. They found that "cervicography for women over age 45 is probably not useful as 8 of 13 cervi grams were uninterpretable." If cervicography is recommended as a screening test or triage tool for patients with minor cytologic abnormalities, the procedure will be performed by many providers. It is likely that providers will have a rate of unsatisfactory cervi grams approaching the upper level of what has been reported (15.5 percent). A substantial number of repeat examinations will have an impact on the cost effectiveness of this test.
Cervicography as a Secondary Triage Tool
The impact of cervicography as a secondary triage tool depends heavily on the comparison strategy used for evaluating atypical or low-grade cytologic findings. It is critical to evaluate diagnostic test characteristics in the context of how the test will influence current practice. The test characteristics delineated in this study show that cervicography can be useful in ruling out disease. The relatively high negative predictive value and low likelihood ratio for a negative result are desirable characteristics of a triage test. With the exception of one study, Schauberger et al,30 the prevalence of high-grade lesions (pretest likelihood of disease) ranges from 3.8 to 7.2 percent, whereas the posttest likelihood of a high-grade lesion after a negative cervi gram ranges from 0.0 to 1.0 percent.
Recently published practice guidelines allow for different management strategies to be applied to women with atypical or low-grade cytologic findings, that is, immediate colposcopy or watchful waiting with repeat Papanicolaou smears. 5 These guidelines seem to reflect practice variation in the community. The posttest likelihoods of high-grade lesions associated with a negative cervigram might be sufficiently low that clinicians who currently recommend immediate colposcopy for women with low-grade abnormal cytologic findings might want to consider a policy of repeat Papanicolaou smears instead of immediate colposcopy if the cervigram is negative. For these providers, cervicography could be useful as a secondary triage tool. Offering colposcopy only to patients with positive findings on a cervi gram will decrease the number of colposcopies performed, and additional cases of high-grade dysplasia missed by the index Papanicolaou smear might be detected.
For providers who follow up with serial Papanicolaou smears to evaluate low-grade abnormalities, cervicography will result in many false-positive referrals for colposcopy. Although additional dysplastic lesions will be detected, whether there is a clinically meaningful advantage to earlier detection of such lesions is unclear. Thirty to 50 percent of low-grade lesions will regress, and it is unlikely that early detection will have an impact on outcome. 39 -41 For high-grade lesions it is less clear whether more immediate detection directed by a positive cervi gram will result in improved outcomes.
Cervkograpby tIS lin Initial Screening Test
Only one study addressed cervicography as an initial screening test. 29 Cervicography had a higher sensitivity than cervical cytology (0.89 and 0.52, respectively) in this study. The specificity of the two techniques was similar (0.92 and 0.94). The study included many patients who had never been screened for cervical cancer by any method. It is likely that inclusion of these patients led to a higher rate of detected high-grade lesions. It will be important for future studies to address cervicography in previously screened populations.
These results suggest that it would be appropriate to undertake further studies comparing the clinical and economic efficiency of cervicography with that of cervical cytology as an initial screening test. Such a study is currently in progress.
Need for Rigorous Assessment of NtnIJ TeeImology
This report 'highlights the importance of rigorously evaluating new technology before its dissemination. As noted by Reid et al, 9 "all new diagnostic technologies, before being 'released,' (should) receive a standardized assessment, using accepted methodological criteria." Improved "methodological standards could raise the quality of diagnostic test information, and the careful predissemination evaluation of diagnostic tests could eliminate useless tests before they receive widespread application."
The results of our analysis support these recommendations. Given the growing interest in alternative strategies for management of low-grade cytologic abnormalities and the increasing number of providers using cervicography, future studies on cervicography must employ rigorous methodologic standards.
Conclusions
Is cervicography a useful test in the evaluation of patients for cervical dysplasia? The claims made on behalf of cervicography are best summarized by Spitzer et alB: "Because patients are so unlikely to return for follow-up, we should optimize our opportunities for early cancer detection by using multiple screening techniques where possible rather than relying on follow-up smears at a later date." The available evidence indicates that the potential usefulness of cervicography is heavily dependent on the management strategy chosen by the provider. Whether patients with minor cytologic abnormalities should undergo immediate colposcopy or repeat Papanicolaou smears is not resolved by a cervigram. Additional, well-designed studies are needed to evaluate this new technology as both a screening test and a sec-ondary triage test before its appropriate use can be defined. Such studies must address the deficiencies of previous research, including verification bias, appropriate selection and description of the population to be studied, the impact of interobserver variability, technical problems with cervi gram interpretation, applicability in different age and risk groups, and impact on the costs of cervical cancer screening.
